Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-014939
Filing Date
2022-10-11
Accepted
2022-10-11 17:00:19
Documents
7
Period of Report
2022-11-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20221116xpre14a.htm PRE 14A 380109
2 GRAPHIC tmb-20221116xpre14a008.jpg GRAPHIC 95973
3 GRAPHIC tmb-20221116xpre14a006.jpg GRAPHIC 2625
4 GRAPHIC tmb-20221116xpre14a009.jpg GRAPHIC 111418
5 GRAPHIC tmb-20221116xpre14a005.jpg GRAPHIC 2746
6 GRAPHIC tmb-20221116xpre14a001.jpg GRAPHIC 5724
7 GRAPHIC tmb-20221116xpre14a004.jpg GRAPHIC 2788
  Complete submission text file 0001558370-22-014939.txt   686778
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39069 | Film No.: 221304648
SIC: 2834 Pharmaceutical Preparations